March 17 (Reuters) - Next Science Ltd (NXS) :
- DUE TO COVID19 OUTBREAK IN U.S., SEEING DISRUPTION TO ACTIVITIES INCLUDING REDUCED HOSPITAL VISITS BY DISTRIBUTION AGENTS
- SALES GROWTH HAS BEEN IMPACTED AND IS LIKELY TO CONTINUE
- TOO EARLY TO REASONABLY ANTICIPATE SALES IN Q2
- EXPECT COMMERCIAL LAUNCH OF 2 NEW PRODUCTS IN U.S. IN H2 2020
News: NXS Next Science Says Seeing Disruption To Activities In U.S. Due To Covid-19 Outbreak
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
14.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $43.16M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $3.155K | 21.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 2150505 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 693072 | 10 |
View Market Depth
| Last trade - 15.59pm 11/09/2025 (20 minute delay) ? |
| NXS (ASX) Chart |